New flu vaccines to be produced by Green Cross soon

Published: 2009-06-11 06:57:00

Updated: 2009-06-11 06:57:00

Green Cross Corporation plans to mass-produce new influenza vaccines by cultivating master seeds supplied by the U.S. Centers for Disease Control and Prevention (CDC) and the U.K. National Institute for Biological Standards and Control (NIBSC) from next month.

“We will be able to overlook inte...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK